Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIVERT: Mycophenolate Mofetil Alone or With Voclosporin for Systemic Lupus
NCT05306873Phase 2Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 2022
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mycophenolate mofetil, voclosporin in systemic lupus erythematosus (SLE), sponsored by National Institute of Allergy and Infectious Diseases. Started Nov 2022; status: terminated.
02
Drugs
mycophenolate mofetilvoclosporin
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT05306873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05306873.